HomeCompareADDLF vs EQR

ADDLF vs EQR: Dividend Comparison 2026

ADDLF yields 0.19% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EQR wins by $17.1K in total portfolio value
10 years
ADDLF
ADDLF
● Live price
0.19%
Share price
$42.00
Annual div
$0.08
5Y div CAGR
49%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.4K
Annual income
$1,143.40
Full ADDLF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — ADDLF vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADDLFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADDLF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADDLF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADDLF
Annual income on $10K today (after 15% tax)
$15.94/yr
After 10yr DRIP, annual income (after tax)
$971.89/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, EQR beats the other by $2,274.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADDLF + EQR for your $10,000?

ADDLF: 50%EQR: 50%
100% EQR50/50100% ADDLF
Portfolio after 10yr
$31.9K
Annual income
$2,481.50/yr
Blended yield
7.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ADDLF
No analyst data
Altman Z
5.0
Piotroski
8/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADDLF buys
0
EQR buys
0
No recent congressional trades found for ADDLF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADDLFEQR
Forward yield0.19%4.73%
Annual dividend / share$0.08$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR49%15.8%
Portfolio after 10y$23.4K$40.5K
Annual income after 10y$1,143.40$3,819.61
Total dividends collected$3.3K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ADDLF vs EQR ($10,000, DRIP)

YearADDLF PortfolioADDLF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$10,728$27.93$11,248$547.57$520.00EQR
2$11,521$41.73$12,701$666.53$1.2KEQR
3$12,389$62.40$14,405$814.59$2.0KEQR
4$13,350$93.45$16,413$999.84$3.1KEQR
5$14,425$140.23$18,795$1,232.92$4.4KEQR
6$15,646$210.99$21,639$1,527.95$6.0KEQR
7$17,060$318.67$25,057$1,903.80$8.0KEQR
8$18,738$483.86$29,197$2,385.87$10.5KEQR
9$20,789$740.07$34,250$3,008.70$13.5KEQR
10$23,388$1,143.40$40,467$3,819.61$17.1KEQR

ADDLF vs EQR: Complete Analysis 2026

ADDLFStock

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Full ADDLF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ADDLF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADDLF vs SCHDADDLF vs JEPIADDLF vs OADDLF vs KOADDLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.